Carsten Worsøe, Novo Nordisk A/S - Qepler Summits And Conferences

Carsten Worsøe

Principal Scientist
Novo Nordisk A/S
Copenhagen, Denmark
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care.

Carsten Worsøe is a principal scientist in an analytical development department at Novo Nordisk.

In his 20 years at Novo Nordisk, his main responsibility has been to develop analytical methods for Extractables and Leachables (E&L) test procedures of new packaging/container closure systems under development.

Within Novo Nordisk Carsten has been one of the main actors to bring relevant people in packaging materials, toxicology, formulation, regulatory and analytical chemistry together to perform risk assessments and strategies for E&L testing in development and supply projects within parenteral delivery (prefilled cartridges, prefilled syringes and pump infusion systems etc.)

Related Sessions:

2nd Annual Pre-Filled
Syringes Summit 2019

Enhance expertise sharing in developing pre-filled syringes and provide attendees with ample networking opportunities.
  • 04 Jun 2019
  • Barcelona, ES
  • Pharma
Day 2: Wednesday, 05 June 2019
BLOCK: COMPONENT SELECTION AND RISK MITIGATION STRATEGIES.
CASE STUDY: Risk mitigation strategies and documentation for extractable, leachable and interactions in PFS
  • Choice of critical components for drug compatibility in PFS
  • Predictive tools for interactions in PFS
  • Relationship between extractables, simulated leachables and leachables in PFS
  • Case studies on leachable assessments in prefilled syringes
View Details